Board/Management Information • Jul 28, 2016
Board/Management Information
Open in ViewerOpens in native device viewer
Novozymes A/S CVR number: 10 00 71 27Major shareholder announcement In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes to 4.999%, previously reported at 5.04% in company announcement no. 16, April 2016.
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,498,025 shares of a nominal value of DKK 30,996,050, equivalent to 4.999% of Novozymes A/S' share capital and 1.95% of the voting rights.
July 28, 2016 Company announcement No. 36
Contact information [email protected] m
Martin Riise +45 3077 0738 [email protected]
Klaus Sindahl +45 5363 0134 [email protected]
Nicolai Kobborg +45 30771348 [email protected]
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27
Novozymes A/S Krogshoejvej 36 2880 Bagsvaerd Denmark
Phone: +45 4446 0000
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.